+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "RNA"

Viral Vector Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2026

  • Report
  • May 2026
  • 300 Pages
  • Global
From
Genomic Collaboration and Licensing Deals 2018-2026 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2026

  • Report
  • May 2026
  • 450 Pages
  • Global
From
From
Cell Therapy Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Cell Therapy Collaboration and Licensing Deals 2016-2026

  • Report
  • May 2026
  • 500 Pages
  • Global
From
From
The Global Exosome Market: Size, Forecast, Trials and Trends, 2026 - Product Thumbnail Image

The Global Exosome Market: Size, Forecast, Trials and Trends, 2026

  • Report
  • September 2026
  • 385 Pages
  • Global
From
From
From
From
From
Loading Indicator

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research. The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market. Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more